All In Biotech

Drug Trial Radar · NCT04833426

Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy

Last checked: Nov 20, 2026Latest source record: May 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 140 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

140

Planned (sponsor's estimate)

Start

Dec 12, 2022

Primary completion

Dec 2027

Study completion Dec 2029

Sponsor

Lead sponsor
Canisius-Wilhelmina HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Besins Healthcare
First posted
Apr 6, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Sexual dysfunction is a common side effect of radical prostatectomy (RP) and has a significant negative impact on quality of life. With age the testosterone level in men declines; around 30% of men over 70 years of age meet the criteria of testosterone deficiency (TD). The negative impact of both TD and RP on sexual performance are likely to add up. The aim of this study is to assess the efficacy and safety of testosterone replacement therapy (TRT) on functional and oncological outcomes in testosterone deficient men following RP for prostate cancer (PCa).

Conditions

  • Prostatic Neoplasms
  • Hypogonadism
  • Testosterone Deficiency

Interventions

  • Testosterone gelDrug

    Topical gel containing testosterone

  • PlaceboDrug

    Topical gel without active substance

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinically relevant (≥12 points) difference in the EPIC-26 sexual functioning domain score, 12 months after radical prostatectomy between groups.Time frame: 12 months

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Amsterdam UMC location VUmc

    Amsterdam, Netherlands · Recruiting

  • Netherlands Cancer Institute

    Amsterdam, Netherlands · Recruiting

  • Rijnstate

    Arnhem, Netherlands · Recruiting

  • Catharina Hospital

    Eindhoven, Netherlands · Recruiting

  • Treant

    Emmen, Netherlands · Recruiting

  • Zuyderland

    Heerlen, Netherlands · Recruiting

  • St. Antonius Hospital

    Nieuwegein, Netherlands · Recruiting

  • Canisius Wilhelmina Ziekenhuis

    Nijmegen, Netherlands · Recruiting

  • Radboud university medical center

    Nijmegen, Netherlands · Recruiting

  • Máxima Medical Centre

    Veldhoven, Netherlands · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.